-
02 Apr 2012 | Department of Health in Hong Kong finds Traditional Chinese Medicines to contain heavy metals and undeclared pharmaceuticals
Traditional Chinese Medicine (TCM) Anshen Bunao Pian (Chung Lien Kulin Brand) has been found by the Department of Health in Hong Kong to contain 55 times the level of mercury permitted in China. Acute mercury poisoning can damage the neurological system and kidneys. The product is manufactured in mainland China and imported by Fung Wah (HK) Company. It is used for treating restlessness and insomnia.
-
29 Feb 2012 | Paiyouji Plus - Fast Acting Slimming Tea found to contain potentially dangerous undeclared pharmaceuticals
Following a safety alert issued in October 2010 about slimming products containing Paiyouji the Agency has received a further complaint about a product called Paiyouji Plus - Fast Acting Slimming Tea.
-
24 Feb 2012 | Herbal slimming products found to contain potentially dangerous undeclared pharmaceuticals
We are advising consumers not to buy the potentially dangerous herbal slimming products specified in this warning, as laboratory tests found evidence of pharmaceutical ingredients not declared on the label that may pose serous health risks.
-
24 Feb 2012 | Advice to consumers not to use unlicensed herbal medicines used for erectile dysfunction
We are advising consumers not to use the various unlicensed herbal medicines used for erectile dysfunction specified in this alert due to concerns about possible side effects.
-
27 Jan 2012 | Consumers are advised not to take unlicensed Butterbur (Petasites hybridus) herbal remedies
The MHRA has recently become aware that unlicensed herbal products containing butterbur (Petasites hybridus) are being marketed in the UK and is warning consumers about the risks associated with the use of these products.
-
15 Dec 2011 | MHRA issues apology to Cambridge Commodities Ltd for incorrectly implicating them in Black Cohosh product withdrawal
MHRA issues apology to Cambridge Commodities Ltd for incorrectly implicating them in Black Cohosh product withdrawal.
-
09 Dec 2011 | FSC Black Cohosh product withdrawn from the market
In response to an urgent notice issued by the MHRA, Bee Health Ltd has agreed to stop marketing FSC Black Cohosh 1000 mg due to concerns about the high dosage of black cohosh in the product.
-
01 Dec 2011 | Health Sciences Authority in Singapore warns of four adulterated herbal products
Health Sciences Authority in Singapore has issued a press release warning the public of four adulterated health products which have been found to contain undeclared pharmaceutical medicines.
-
10 Nov 2011 | Department of Health in Hong Kong finds undeclared pharmaceutical ingredients in herbal remedy Cardiotium
The Department of Health in Hong Kong have recalled and issued a warning not to use the herbal product specified below the herbal remedy Cardiotium, which is marketed as treating coronary heart disease, as it would found to contain undeclared pharmaceutical ingredients.
-
07 Sep 2011 | Unlicensed herbal product found to contain the antihistamine, chlorphenamine - update
Beline Capsules have been found to contain the undeclared pharmaceutical ingredients, which is consistent with earlier findings by the Danish Medicines Agency.
Loading MHRA search...
Page last modified:
08 December 2011
Head office: 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ
General enquiries: info@mhra.gsi.gov.uk
To contact us about this website, use our feedback form